Characterization of VDAC1 as a plasma membrane NADH-oxidoreductase

被引:15
|
作者
Baker, MA
Ly, JD
Lawen, A
机构
[1] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia
[2] Univ Newcastle, Sch Environm & Life Sci, Reprod Sci Grp, ARC Ctr Excellence Biotechnol & Dev, Newcastle, NSW 2308, Australia
关键词
transplasma membrane electron transport; NADH; VDAC1; ferricyanide reductase;
D O I
10.1002/biof.552210143
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have recently demonstrated that voltage dependent anion selective channel I (porin, isoform 1) can function as a transplasma membrane NADH:ferricyanide-reductase. However, both the specific redox characteristics and the mechanism of electron transport in this enzyme presently remain unclear. Here we demonstrate that the redox capability of porin I is specific for ferricyanide as this same enzyme cannot reduce DCIP or cytochrome c in vitro. Furthermore, NADH-dependent ferricyanide reduction associated with VDAC1 is not sensitive to the anion channel inhibitors DIDS and dextran sulfate. However, this activity can be inhibited by thiol chelators, suggesting that at least one of the two cysteine groups present in VDAC1 are critical for electron transfer. We propose a model on how electron transport may occur in VDAC1.
引用
收藏
页码:215 / 221
页数:7
相关论文
共 50 条
  • [31] External mitochondrial NADH-dependent reductase of redox cyclers: VDAC1 or Cyb5R3?
    Nikiforova, Anna B.
    Saris, Nils-Erik L.
    Kruglov, Alexey G.
    FREE RADICAL BIOLOGY AND MEDICINE, 2014, 74 : 74 - 84
  • [32] Nek1 regulates cell death and mitochondrial membrane permeability through phosphorylation of VDAC1
    Chen, Yumay
    Craigen, William J.
    Riley, Daniel J.
    CELL CYCLE, 2009, 8 (02) : 257 - 267
  • [33] VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis
    Ben-Hail, Danya
    Shoshan-Barmatz, Varda
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2016, 1863 (07): : 1612 - 1623
  • [34] Identification of VDAC1 as a cardioprotective target of Ginkgolide B
    Wu, Tingbiao
    Li, Deyao
    Chen, Qiuyu
    Kong, Dezhi
    Zhu, Hongxuan
    Zhou, Hefeng
    Zhang, Qingwen
    Cui, Guozhen
    CHEMICO-BIOLOGICAL INTERACTIONS, 2025, 406
  • [35] VDAC1 at the Intersection of Cell Metabolism, Apoptosis, and Diseases
    Shoshan-Barmatz, Varda
    Shteinfer-Kuzmine, Anna
    Verma, Ankit
    BIOMOLECULES, 2020, 10 (11) : 1 - 40
  • [36] NADH-FERRICYANIDE OXIDOREDUCTASE IS PRESENT ON BOTH SIDES OF PLANT PLASMA-MEMBRANE
    BERCZI, A
    BRIGHTMAN, AO
    PLANT SCIENCE, 1994, 97 (01) : 47 - 52
  • [37] VDAC1, mitochondrial dysfunction, and Alzheimer's disease
    Shoshan-Barmatz, Varda
    Nahon-Crystal, Edna
    Shteinfer-Kuzmine, Anna
    Gupta, Rajeev
    PHARMACOLOGICAL RESEARCH, 2018, 131 : 87 - 101
  • [38] Peripheral Binding of Hexokinase-2 to the Rim of VDAC1 Mediated by the Mitochondrial Outer Membrane
    Haloi, Nandan
    Wen, Po-Chao
    Cheng, Qunli
    Yang, Meiying
    Camara, Amadou K.
    Kwok, Wai-Meng
    Tajkhorshid, Emad
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 448A - 449A
  • [39] PGC1α and VDAC1 expression in endometrial cancer
    Wersall, Ofra Castro
    Lofstedt, Lina
    Govorov, Igor
    Mints, Miriam
    Gabrielson, Marike
    Shoshan, Maria
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (02) : 1 - 6
  • [40] Prediction and biological analysis of yeast VDAC1 phosphorylation
    Sousa, Andre D.
    Costa, Ana Luisa
    Costa, Vitor
    Pereira, Clara
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 753